According to an announcement from the U.S. Food and Drug Administration (FDA) on April 4th, the FDA has issued 119 warning letters to physical retailers selling a variety of flavored ZYN nicotine pouches between October 2023 and February 2024, and has proposed 41 civil monetary penalties.
The FDA has issued warning letters to three online retailers for selling unauthorized flavors of ZYN nicotine pouches.
Nicotine pouches are a tobacco product containing nicotine powder or nicotine salt in a small pouch that does not require cutting, grinding, or using tobacco leaves. They can be placed between the lip and gums to absorb nicotine. According to the 2023 National Youth Tobacco Survey, approximately 1.5% of teenagers reported using nicotine pouches, a percentage that has remained stable in recent years. However, reports received by the FDA suggest that the popularity of these products among teenagers may be increasing, even becoming a trending topic on social media.
Dr. Brian King, Director of the FDA Center for Tobacco Products, stated:
Although current data does not show an increase in the use of nicotine pouches among adolescents, the FDA remains cautious about all tobacco products that may appeal to teenagers. We will continue to closely monitor the use of these products by adolescents. Selling tobacco products to anyone under the legal age is unacceptable, and if violations occur, the FDA will penalize retailers, especially those who continue to violate the rules after being warned.
Selling any tobacco products, including cigarettes, e-cigarettes, cigars, and nicotine pouches, to individuals under the age of 21 is illegal under US law. This minimum age restriction applies to all retailers and consumers without exception.
Newly launched tobacco products must obtain authorization from the FDA, and to obtain FDA authorization, products must provide sufficient scientific evidence when submitting an application to prove that they meet the public health standards required by law. As of April 2024, no "ZYN" products have been granted sales authorization by the FDA.
The FDA has issued 41 civil penalty complaints for selling to minors, requesting a total compensation exceeding $55,000. In today's announcement, three of the letters were directed at online retailers selling unauthorized ZYN nicotine pouches in flavors such as espresso, black cherry, lemon Sprite, and cucumber lime.
The FDA has stated that nicotine pouches, popular among teenagers, can be harmful to brain development and may affect attention, learning, and memory. Therefore, the use of any tobacco product by teenagers is unsafe. The FDA has urged parents, teachers, and other adults to be aware of teenagers using nicotine pouches and the potential risks to their health.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
